Knowledge Graph
Graph explorer
Search resolved entities, walk their edges, and read the sentence behind every one.
Entities25 of 207,987
- large language modeltechnology1,048 mentions
- robotic manipulationmarket834 mentions
- artificial intelligencetechnology739 mentions
- reinforcement learningtechnology492 mentions
- density-functional theorytechnology386 mentions
- Transformertechnology372 mentions
- vision-language-action modeltechnology355 mentions
- agentic AItechnology353 mentions
- Vision-Language Modeltechnology321 mentions
- U.S. Food and Drug Administrationorganization320 mentions
- Microsoftorganization291 mentions
- Googleorganization277 mentions
- NVIDIAorganization265 mentions
- Model Context Protocoltechnology232 mentions
- machine learningtechnology204 mentions
- MarketsandMarketsorganization199 mentions
- Claudeproduct192 mentions
- AI agenttechnology188 mentions
- ChatGPTproduct178 mentions
- Anthropicorganization177 mentions
- integrated sensing and communicationtechnology176 mentions
- Amazon Web Services, Inc.organization174 mentions
- OpenAIorganization172 mentions
- diffusion modeltechnology170 mentions
- IBMorganization163 mentions
Entity
Calidi Biotherapeutics, Inc.
organization2 mentionslast seen Sep 25, 2026
Biotechnology company developing targeted genetic medicines using its RedTail platform.
Relationships 6
- Calidi Biotherapeutics, Inc.developsCLD-40199% confidence2 sources
- Calidi Biotherapeutics, Inc.developsRedTail platform99% confidence2 sources
- Calidi Biotherapeutics, Inc.employsAndrew Jackson97% confidence1 source
- Calidi Biotherapeutics, Inc.funded byRegistered Direct Offering September 202695% confidence1 source
- Calidi Biotherapeutics, Inc.conforms toNYSE American Company Guide Section 1003(a)(ii)90% confidence1 source
- NYSE AmericanapprovesCalidi Biotherapeutics, Inc.85% confidence1 source
Relationship
Calidi Biotherapeutics, Inc.developsRedTail platform
99% confidence2 supporting mentions
Either name opens that entity’s relationships.
Sources 2
- filingSEC EDGARSep 25, 2026Calidi Biotherapeutics, Inc. 8-K: Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
The Company's proprietary RedTail platform features an engineered enveloped oncolytic virus
- filingSEC EDGARSep 22, 2026Calidi Biotherapeutics, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
Calidi Biotherapeutics, Inc. (NYSE American: CLDI) ("Calidi" or the "Company"), a biotechnology company pioneering the development of targeted genetic medicines